North America
North America oligonucleotide synthesis market holds the largest share due to advanced healthcare infrastructure, significant R&D activities in molecular diagnostics and therapeutics, and the presence of leading biotechnology companies and research institutions. The United States dominates the region with high adoption rates of oligonucleotide-based therapies for chronic...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian